The global pacemaker market is witnessing steady growth, with a valuation of USD 5.45 billion in 2024. It is expected to rise to USD 5.66 billion by 2025, and reach approximately USD 7.89 billion by 2034, expanding at a CAGR of 3.75% from 2025 to 2034.
Pacemakers are essential cardiac devices used to regulate abnormal heart rhythms, and their demand is increasing due to aging populations and rising incidences of cardiovascular diseases worldwide.
2024 Valuation: USD 5.45 Billion
2034 Projection: USD 7.89 Billion
CAGR (2025–2034): 3.75%
Leading Region: North America
Fastest-Growing Region: Asia-Pacific
Top Product Segment: Implantable Pacemakers
About: Medtronic is a global leader in medical technology with a presence in over 150 countries.
Products: Offers a broad range of implantable pacemakers, including MRI-safe and leadless devices.
Market Cap: ~$105 Billion
About: A prominent player in medical device innovation focused on minimally invasive therapies.
Products: Manufactures advanced pacemaker systems with features like Bluetooth connectivity and automatic adjustments.
Market Cap: ~$90 Billion
About: Abbott is a diversified healthcare company excelling in diagnostics, devices, and nutrition.
Products: Known for its Assurity and Endurity pacemaker lines.
Market Cap: ~$175 Billion
About: A German company known for precision-engineered cardiac devices.
Products: Offers implantable pacemakers and remote monitoring solutions.
Market Cap: Privately held
About: Headquartered in Shanghai, MicroPort is a global innovator in interventional and structural heart devices.
Products: Provides compact, cost-effective pacemaker systems.
Market Cap: ~$2.5 Billion
About: A London-based company focused on neuromodulation and cardiac surgery technologies.
Products: Offers pacemakers as part of its cardiopulmonary product portfolio.
Market Cap: ~$3 Billion
About: A German manufacturer of cardiovascular devices.
Products: Specializes in temporary external pacemakers for clinical use.
Market Cap: Privately held
About: A Chinese firm providing integrated medical devices and equipment.
Products: Offers implantable pacemakers and leads.
Market Cap: ~$4 Billion
About: One of India’s leading pacemaker manufacturers.
Products: Offers various models of implantable pacemakers including single and dual chamber.
Market Cap: ~$40 Million
About: U.S.-based, ZOLL is now part of Japan’s Asahi Kasei Group.
Products: Known for external defibrillators and temporary pacing systems.
Market Cap: Asahi Kasei ~$10 Billion
About: An Italian company dedicated to cardiac rhythm management.
Products: Designs high-tech pacemakers and implantable cardiac monitors.
Market Cap: Privately held
About: Merged into LivaNova, Sorin was known for its stronghold in cardiac devices.
Products: Specialized in bradycardia therapy and implantable pacemakers.
Market Cap: Now part of LivaNova
About: A recognized brand in the Indian pacemaker industry.
Products: Offers cost-effective and locally manufactured cardiac pacemakers.
Market Cap: Privately held
About: A global leader in vascular interventions, recently spun off from Cardinal Health.
Products: Offers pacing and cardiac electrophysiology products.
Market Cap: Cardinal Health ~$24 Billion
About: A U.S.-based firm with a specialty in innovative pacing leads and delivery systems.
Products: Provides temporary and diagnostic cardiac devices.
Market Cap: Acquired by Integer Holdings (~$3 Billion Market Cap)
About: Renowned for its transcatheter heart valves and surgical structural heart therapies.
Products: Involved indirectly in pacing-related accessories and heart care solutions.
Market Cap: ~$50 Billion
About: A Japanese company known for diagnostic and therapeutic cardiology devices.
Products: Manufactures temporary pacemakers and cardiac monitors.
Market Cap: ~$1.5 Billion
About: A French company traditionally focused on orthopedic implants, with expansion into medical devices.
Products: Has diversified into cardiac rhythm solutions.
Market Cap: ~$15 Million
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
1. What is the expected market size of the pacemaker market by 2034?
The market is projected to reach approximately USD 7.89 billion by 2034.
2. What factors are driving growth in the pacemaker market?
Key drivers include the increasing prevalence of cardiovascular diseases, an aging global population, and advancements in device miniaturization and connectivity.
3. Which region is dominating the pacemaker market currently?
North America led the global market in revenue in 2024 due to advanced healthcare infrastructure and high adoption rates.
4. Which region is expected to grow the fastest?
Asia-Pacific is projected to witness the fastest CAGR during the forecast period, driven by rising healthcare investments and growing elderly population.
5. What type of pacemaker leads the market in 2024?
The implantable pacemakers segment holds the largest revenue share in 2024, favored for their long-term performance and safety.
Source : https://www.towardshealthcare.com/insights/pacemaker-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5896
The global digital health and wellness market is projected to expand from US$ 498.99 billion in 2024 to US$ 3,568.11… Read More
The global radiopharmaceutical market is projected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034,… Read More
The U.S. life science market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the… Read More
The U.S. cell therapy market size is forecast to grow at a CAGR of 21.46%, from USD 8.04 billion in… Read More
The global animal biotechnology market was USD 28.17 billion in 2024, rose to USD 30.97 billion in 2025, and is… Read More
The global ophthalmology devices market was US$ 7.51 billion in 2024, rose to US$ 7.89 billion in 2025, and is… Read More